Current Report Filing (8-k)
February 17 2021 - 11:11AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date
of Report (date of earliest event reported): February 4, 2021
China
Botanic Pharmaceutical, Inc.
(Exact
name of Registrant as specified in its charter)
Nevada
|
|
001-34808
|
|
88-1273503
|
(State or other jurisdiction of
|
|
(Commission File Number)
|
|
(IRS employer
|
incorporation or organization)
|
|
|
|
identification no.)
|
1185
Avenue of the Americas, 3rd Floor. New York,
New York 10036.
|
|
11572
|
(Address of principal
executive offices)
|
|
(Zip Code)
|
Registrant’s
telephone number, including area code: 646 768 8417
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which
registered
|
Common
Stock
|
|
CBPI
|
|
OTC:Pink
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.01 Changes in Control of Registrant.
On
February 4, 2021 as a result of a custodianship in Clark County, Nevada, Case Number: A-20-827231-B Custodian Ventures LLC (“Custodian”)
was appointed custodian of China Botanic Pharmaceutical, Inc. (the “Company”).
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
On
February 4, 2021, Custodian appointed David Lazar as the Company’s Chief Executive Officer, President, Secretary, Chief
Financial Officer, Chief Executive Officer and Chairman of the Board of Directors.
David
Lazar, 30, is a private investor. Mr. Lazar has been a partner at Zenith Partners International since 2013, where he specializes
in research and development, sales and marketing. From 2014 through 2015. Since February of 2018, Mr. Lazar has been the managing
member of Custodian Ventures LLC, where he specializes in assisting distressed public companies. Since March 2018, David has acted
as the managing member of Activist Investing LLC, which specializes in active investing in distressed public companies. David
has a diverse knowledge of financial, legal and operations management; public company management, accounting, audit preparation,
due diligence reviews and SEC regulations.
Section
8 - Other Events
Item
8.01. Other Events.
The
Registrant’s current contact information is listed below:
Address:
1185 Avenue of the Americas, 3rd Floor. New York, New York 10036.
Phone
number: 646-768-8417
Email:
David@Activistinvestingllc.com
The
Registrant’s President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors
is David Lazar, who may be reached at the Registrant’s address above.
Item
9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
|
China Botanic Pharmaceutical Inc.
|
|
|
Dated: February
17, 2021
|
By:
|
/s/ David Lazar
|
|
|
David Lazar
|
|
|
Chief Executive Officer
|
EXHIBIT
INDEX
3
China Botanic Pharmaceut... (PK) (USOTC:CBPI)
Historical Stock Chart
From May 2024 to Jun 2024
China Botanic Pharmaceut... (PK) (USOTC:CBPI)
Historical Stock Chart
From Jun 2023 to Jun 2024